Frank Tori named FDA chief scientist

Apr 09, 2008

The U.S. Food and Drug Administration has appointed Dr. Frank Torti as its principal deputy commissioner and new chief scientist.

FDA Commissioner Dr. Andrew von Eschenbach said the newly created chief scientist position was mandated by the Food and Drug Administration Amendments Act of 2007.

"Dr. Torti's impressive clinical and scientific credentials are an excellent match for the work we do on a daily basis to promote and protect the nation's health as a science-based and science-led agency," von Eschenbach said. "FDA's chief scientist will ensure that the foundation of the FDA's regulatory structure will always be state-of-the-art science."

A clinician, scientist and researcher in molecular oncology, Torti is currently serving as a professor at the Wake Forest University School of Medicine in Winston-Salem, N.C.

Torti received his bachelor's and master's degrees from Johns Hopkins University, his medical degree from Harvard Medical School and his master of public health degree from the Harvard School of Public Health.

He will assume his new post next month.

Copyright 2008 by United Press International

Explore further: Cambodia bans 'virgin surgery' adverts

add to favorites email to friend print save as pdf

Related Stories

How do people post important life events on Facebook?

Jan 20, 2015

When Facebook users share information on important life events, do they prefer to do so directly (detailed status updated or wall posts) or indirectly (photos, change of job title)? How a person chooses to ...

Doing the right thing

Jan 20, 2015

General Motors is in the midst of a series of large-scale, costly automobile recalls, and the process has engendered an assessment of the company in the public arena that isn't particularly flattering at ...

Recommended for you

Cambodia bans 'virgin surgery' adverts

23 hours ago

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.